Company announcements

Announcement type

All

Price-sensitive

Stock code or name

leave blank for all companies

Headline

leave blank for all announcements

Sector

Market Cap ($m)

Announcement date

View top

announcements

Order By

Ascending

Descending

Reset Filters

Search Results

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,196	Update - Notification of buy-back - NEU	20 May 2025 8:26AM	$12.630	$17.320	risen by 37.13%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,196	Update - Notification of buy-back - NEU	19 May 2025 8:52AM	$13.190	$17.320	risen by 31.31%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,196	Update - Notification of buy-back - NEU	16 May 2025 9:11AM	$12.960	$17.320	risen by 33.64%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,196	Update - Notification of buy-back - NEU	15 May 2025 8:00AM	$13.180	$17.320	risen by 31.41%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,196	Update - Notification of buy-back - NEU	14 May 2025 8:20AM	$12.330	$17.320	risen by 40.47%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,196	NEU receives FDA minutes and re-confirms Phase 3 endpoints	13 May 2025 2:06PM	$12.385	$17.320	risen by 39.85%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,196	Update - Notification of buy-back - NEU	13 May 2025 9:04AM	$12.020	$17.320	risen by 44.09%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,196	Update - Notification of buy-back - NEU	12 May 2025 9:09AM	$13.290	$17.320	risen by 30.32%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,196	Update - Notification of buy-back - NEU	9 May 2025 7:30AM	$12.800	$17.320	risen by 35.31%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,196	Update - Notification of buy-back - NEU	8 May 2025 9:08AM	$12.620	$17.320	risen by 37.24%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,196	DAYBUE Q1 2025 net sales US$84.6m up 11% from Q1 2024	8 May 2025 9:02AM	$12.620	$17.320	risen by 37.24%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,196	Update - Notification of buy-back - NEU	7 May 2025 7:31AM	$12.150	$17.320	risen by 42.55%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,196	Notification of cessation of securities - NEU	6 May 2025 8:51AM	$12.300	$17.320	risen by 40.81%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,196	Update - Notification of buy-back - NEU	6 May 2025 8:50AM	$12.300	$17.320	risen by 40.81%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,196	Becoming a substantial holder	5 May 2025 6:31PM	$12.300	$17.320	risen by 40.81%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,196	Update - Notification of buy-back - NEU	5 May 2025 9:14AM	$12.440	$17.320	risen by 39.23%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,196	Neuren appoints Daryl DeKarske to executive team	2 May 2025 9:09AM	$11.800	$17.320	risen by 46.78%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,196	Update - Notification of buy-back - NEU	2 May 2025 8:09AM	$11.800	$17.320	risen by 46.78%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,196	Update - Notification of buy-back - NEU	1 May 2025 8:53AM	$11.660	$17.320	risen by 48.54%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,196	Update - Notification of buy-back - NEU	30 Apr 2025 7:55AM	$11.560	$17.320	risen by 49.83%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,196	Update - Notification of buy-back - NEU	29 Apr 2025 7:33AM	$10.990	$17.320	risen by 57.60%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,196	Update - Notification of buy-back - NEU	28 Apr 2025 9:08AM	$11.340	$17.320	risen by 52.73%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,196	Virtual AGM online guide	24 Apr 2025 9:26AM	$11.010	$17.320	risen by 57.31%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,196	Notice of Annual General Meeting/Proxy Form	24 Apr 2025 9:20AM	$11.010	$17.320	risen by 57.31%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,196	Update - Notification of buy-back - NEU	24 Apr 2025 8:53AM	$11.010	$17.320	risen by 57.31%

101 - 125 of 821 results

Page 5 of 33

+ Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.